Stavros Athanasiou

ORCID: 0000-0003-0005-0369
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pelvic floor disorders treatments
  • Urinary Bladder and Prostate Research
  • Anorectal Disease Treatments and Outcomes
  • Urinary Tract Infections Management
  • Endometriosis Research and Treatment
  • Pelvic and Acetabular Injuries
  • Menopause: Health Impacts and Treatments
  • Sexual function and dysfunction studies
  • Uterine Myomas and Treatments
  • Hernia repair and management
  • Anesthesia and Pain Management
  • Diverticular Disease and Complications
  • Endometrial and Cervical Cancer Treatments
  • Urological Disorders and Treatments
  • Bladder and Urothelial Cancer Treatments
  • Cardiac, Anesthesia and Surgical Outcomes
  • Estrogen and related hormone effects
  • Reproductive tract infections research
  • Ureteral procedures and complications
  • Enhanced Recovery After Surgery
  • Maternal and fetal healthcare
  • Music Therapy and Health
  • Laser Applications in Dentistry and Medicine
  • Anesthesia and Sedative Agents
  • Dermatologic Treatments and Research

National and Kapodistrian University of Athens
2016-2025

Aristotle University of Thessaloniki
2025

Alexandra Hospital
2015-2024

École Polytechnique Fédérale de Lausanne
2024

Quantum Devices (United States)
2023-2024

University of Copenhagen
2023-2024

Spital Lachen
2024

Committee on Publication Ethics
2023

Niels Brock
2023

Stavros
2021

Microablative fractional CO2 laser has been proven to determine tissue remodeling with neoformation of collagen and elastic fibers on atrophic skin. The aim our study is evaluate the effects microablative postmenopausal women vulvovaginal atrophy using an ex vivo model.This a prospective cohort trial. Consecutive managed pelvic organ prolapse surgical operation were enrolled. After fascial plication, redundant vaginal edge one side was treated (SmartXide2; DEKA Laser, Florence, Italy). Five...

10.1097/gme.0000000000000401 article EN Menopause The Journal of The North American Menopause Society 2015-01-21

Incontinence has a greater detrimental effect on quality of life than other symptoms overactive bladder (OAB) and is often difficult to treat with antimuscarinic monotherapy. To evaluate the efficacy safety tolerability combination (solifenacin 5 mg mirabegron 50 mg) versus solifenacin or 10 in OAB patients remaining incontinent after 4 wk mg. despite daily during 4-wk single-blind run-in were randomised 1:1:1 double-blind for 12 wk. Patients receiving initiated 25 increasing week 4. The...

10.1016/j.eururo.2016.02.030 article EN cc-by-nc-nd European Urology 2016-03-08

To assess the effect of microablative fractional CO2 laser (MFCO2-Laser) therapy on vaginal microenvironment postmenopausal women.Three therapies at monthly intervals were applied in women with moderate to severe symptoms genitourinary syndrome menopause, pH fluid >4.5 and superficial epithelial cells smear <5%. Vaginal values, fresh wet mount microscopy, Gram stain aerobic anaerobic cultures evaluated baseline 1 month after each subsequent therapy. Nugent score Hay-Ison criteria used...

10.1080/13697137.2016.1212006 article EN Climacteric 2016-08-24

Purpose This study aimed to clarify the efficacy of intravaginal CO2-laser treatment in postmenopausal women with genitourinary syndrome menopause (GSM).Materials and methods double-blind, randomized, sham-controlled trial included diagnosed GSM bothersome dryness dyspareunia. Treatment consisted three sessions. Active treatments (active group) were compared sham (sham primary endpoints being changes dyspareunia intensity, as assessed by 10-cm visual analog scale. Secondary follows: Female...

10.1080/13697137.2020.1829584 article EN Climacteric 2020-10-22

Abstract Objective To evaluate the efficacy and safety of non‐ablative vaginal Er:YAG laser device in stress urinary incontinence (SUI) treatment. Methods We conducted a multicenter blinded randomized sham‐controlled trial which women with urodynamic SUI were randomization to active arm using therapy, sham handpiece. Patients received two treatments 1 month apart. The primary outcomes measure was h pad weight test measured at 6 months. Secondary durability treatment success 12 months,...

10.1002/ijgo.15222 article EN cc-by-nc-nd International Journal of Gynecology & Obstetrics 2023-11-05

Objective: To image the striated urethral sphincter (rhabdosphincter) using three-dimensional ultrasound and to compare its size in women with genuine stress incontinence continent controls. Methods: Women no previous continence or prolapse surgery had transvaginal sonography a 7.5-MHz mechanical sector endoprobe real-time facilities. Three perpendicular planes were displayed simultaneously on screen. Manipulation of stored images allowed detailed morphologic assessment urethra at different...

10.1016/s0029-7844(99)00247-1 article EN Obstetrics and Gynecology 1999-08-01

To assess the relationship between prolapse recurrence and some risk factors in a group of women submitted to reconstructive pelvic surgery.Women referred our Urogynaecological Units complaining symptoms were prospectively included. We excluded who affected by apical vaginal >stage I after previous hysterectomy. All had surgery with traditional techniques without using grafts. Each woman was reassessed at 1, 6, 12 months then yearly postoperatively. defined as descent >or=II stage involving...

10.1002/nau.20639 article EN Neurourology and Urodynamics 2009-02-12

Abstract Introduction and Hypothesis Standardized terminology has yet to be developed for reporting the outcomes surgery pelvic organ prolapse (POP). Methods This report combines input of Terminology Standardization Committees International Urogynecological Association (IUGA) Continence Society (ICS) a joint Working Group on this topic, as well expert external referees. The aim was present standardized definitions propose structure surgical procedures POP. An extensive drafting review...

10.1002/nau.22238 article EN Neurourology and Urodynamics 2012-04-01
Coming Soon ...